Literature DB >> 17073557

Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.

Joshua S M Woodworth1, Samuel M Behar.   

Abstract

There are more cases of tuberculosis in the world today than at any other time in history. The global epidemic has generated intense interest into the immunological mechanisms that control infection. Although CD4+ T cells play a critical role in host immunity to Mycobacterium tuberculosis, there is considerable interest in understanding the role of other T cell subsets in preventing disease development following infection. CD8+ T cells are required for optimum host defense following M. tuberculosis infection, which has led to investigation into how this protective effect is mediated. A critical review of recent literature regarding the role of CD8+ T cells in protective immunity to M. tuberculosis infection is now required to address the strengths and weaknesses of these studies. In this article, we evaluate the evidence that CD8+ T cells are critical in immunity to M. tuberculosis infection. We discuss the specific mycobacterial proteins that are recognized by CD8+ T cells elicited during infection. Finally, we examine the effector mechanisms of CD8+ T cells generated during infection and synthesize recent studies to consider the protective roles that these T cells serve in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17073557      PMCID: PMC3134450          DOI: 10.1615/critrevimmunol.v26.i4.30

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  222 in total

1.  Differences between T cell epitopes recognized after immunization and after infection.

Authors:  Thorsten U Vogel; Helen Horton; Deborah H Fuller; Donald K Carter; Kathy Vielhuber; David H O'Connor; Tim Shipley; Jim Fuller; Gerd Sutter; Volker Erfle; Nancy Wilson; Louis J Picker; David I Watkins
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

Review 2.  Evolutionary constraints on CD1 structure: insights from comparative genomic analysis.

Authors:  Christopher C Dascher; Michael B Brenner
Journal:  Trends Immunol       Date:  2003-08       Impact factor: 16.687

3.  Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti.

Authors:  Alexander S Pym; Priscille Brodin; Roland Brosch; Michel Huerre; Stewart T Cole
Journal:  Mol Microbiol       Date:  2002-11       Impact factor: 3.501

4.  The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue.

Authors:  Tsungda Hsu; Suzanne M Hingley-Wilson; Bing Chen; Mei Chen; Annie Z Dai; Paul M Morin; Carolyn B Marks; Jeevan Padiyar; Celia Goulding; Mari Gingery; David Eisenberg; Robert G Russell; Steven C Derrick; Frank M Collins; Sheldon L Morris; C Harold King; William R Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-13       Impact factor: 11.205

5.  Immune control of tuberculosis by IFN-gamma-inducible LRG-47.

Authors:  John D MacMicking; Gregory A Taylor; John D McKinney
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

6.  Reactivation of latent tuberculosis infection in TNF-deficient mice.

Authors:  Tania Botha; Bernhard Ryffel
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

7.  Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis.

Authors:  Ulrich E Schaible; Florian Winau; Peter A Sieling; Karsten Fischer; Helen L Collins; Kristine Hagens; Robert L Modlin; Volker Brinkmann; Stefan H E Kaufmann
Journal:  Nat Med       Date:  2003-07-20       Impact factor: 53.440

8.  TNF-dependent BALB/c murine macrophage apoptosis following Mycobacterium tuberculosis infection inhibits bacillary growth in an IFN-gamma independent manner.

Authors:  J Keane; B Shurtleff; H Kornfeld
Journal:  Tuberculosis (Edinb)       Date:  2002       Impact factor: 3.131

9.  Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis.

Authors:  S-J Ha; B-Y Jeon; S-C Kim; D-J Kim; M-K Song; Y-C Sung; S-N Cho
Journal:  Gene Ther       Date:  2003-09       Impact factor: 5.250

10.  HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells.

Authors:  Amy S Heinzel; Jeff E Grotzke; Rebecca A Lines; Deborah A Lewinsohn; Andria L McNabb; Daniel N Streblow; Veronique M Braud; Heather J Grieser; John T Belisle; David M Lewinsohn
Journal:  J Exp Med       Date:  2002-12-02       Impact factor: 14.307

View more
  76 in total

1.  Concomitant activation and antigen uptake via human dectin-1 results in potent antigen-specific CD8+ T cell responses.

Authors:  Ling Ni; Ingrid Gayet; Sandra Zurawski; Dorothee Duluc; Anne-Laure Flamar; Xiao-Hua Li; Amy O'Bar; Sandra Clayton; Anna Karolina Palucka; Gerard Zurawski; Jacques Banchereau; SangKon Oh
Journal:  J Immunol       Date:  2010-08-20       Impact factor: 5.422

2.  Correlation of Single Nucleotide Polymorphism 35-Kb Upstream of HLA-C and Clinical Profile of Multidrug-Resistant Tuberculosis.

Authors:  Umi Hani' Vismayanti Lismana; Afiono Agung Prasetyo
Journal:  J Clin Diagn Res       Date:  2015-09-01

3.  MHC-restricted Ag85B-specific CD8+ T cells are enhanced by recombinant BCG prime and DNA boost immunization in mice.

Authors:  Shihoko Komine-Aizawa; Jiansheng Jiang; Satoru Mizuno; Satoshi Hayakawa; Kazuhiro Matsuo; Lisa F Boyd; David H Margulies; Mitsuo Honda
Journal:  Eur J Immunol       Date:  2019-06-19       Impact factor: 5.532

4.  Immunogenicity and protective efficacy of DMT liposome-adjuvanted tuberculosis subunit CTT3H vaccine.

Authors:  Xindong Teng; Maopeng Tian; Jianrong Li; Songwei Tan; Xuefeng Yuan; Qi Yu; Yukai Jing; Zhiping Zhang; Tingting Yue; Lei Zhou; Xionglin Fan
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

5.  Shortened Intervals during Heterologous Boosting Preserve Memory CD8 T Cell Function but Compromise Longevity.

Authors:  Emily A Thompson; Lalit K Beura; Christine E Nelson; Kristin G Anderson; Vaiva Vezys
Journal:  J Immunol       Date:  2016-02-22       Impact factor: 5.422

6.  Ectopic activation of Mycobacterium tuberculosis-specific CD4+ T cells in lungs of CCR7-/- mice.

Authors:  Sofia Olmos; Sabriya Stukes; Joel D Ernst
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

7.  Potent immune responses of Ag-specific Vgamma2Vdelta2+ T cells and CD8+ T cells associated with latent stage of Mycobacterium tuberculosis coinfection in HIV-1-infected humans.

Authors:  Lingyun Shao; Wenhong Zhang; Shu Zhang; Crystal Y Chen; Weimin Jiang; Yunya Xu; Chengyan Meng; Xinhua Weng; Zheng W Chen
Journal:  AIDS       Date:  2008-11-12       Impact factor: 4.177

8.  Mycobacterium tuberculosis-specific CD8+ T cells require perforin to kill target cells and provide protection in vivo.

Authors:  Joshua S Woodworth; Ying Wu; Samuel M Behar
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

9.  A critical role for CD8 T cells in a nonhuman primate model of tuberculosis.

Authors:  Crystal Y Chen; Dan Huang; Richard C Wang; Ling Shen; Gucheng Zeng; Shuyun Yao; Yun Shen; Lisa Halliday; Jeff Fortman; Milton McAllister; Jim Estep; Robert Hunt; Daphne Vasconcelos; George Du; Steven A Porcelli; Michelle H Larsen; William R Jacobs; Barton F Haynes; Norman L Letvin; Zheng W Chen
Journal:  PLoS Pathog       Date:  2009-04-17       Impact factor: 6.823

10.  Host ER-parasitophorous vacuole interaction provides a route of entry for antigen cross-presentation in Toxoplasma gondii-infected dendritic cells.

Authors:  Romina S Goldszmid; Isabelle Coppens; Avital Lev; Pat Caspar; Ira Mellman; Alan Sher
Journal:  J Exp Med       Date:  2009-01-19       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.